M Cara

2.5k total citations
96 papers, 2.0k citations indexed

About

M Cara is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, M Cara has authored 96 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Organic Chemistry, 31 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in M Cara's work include Synthesis and biological activity (33 papers), Synthesis and Biological Evaluation (15 papers) and Click Chemistry and Applications (11 papers). M Cara is often cited by papers focused on Synthesis and biological activity (33 papers), Synthesis and Biological Evaluation (15 papers) and Click Chemistry and Applications (11 papers). M Cara collaborates with scholars based in Italy, Spain and United States. M Cara's co-authors include Pier Giovanni Baraldi, Romeo Romagnoli, María Dora Carriòn, Ernest Hamel, Olga Cruz‐López, Delia Preti, Andrea Brancale, Giampietro Viola, Giuseppe Basso and Roberta Bortolozzi and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

M Cara

94 papers receiving 2.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M Cara 1.3k 685 219 175 167 96 2.0k
Alaa M. Hayallah 856 0.7× 780 1.1× 257 1.2× 126 0.7× 174 1.0× 67 1.7k
Olga Bruno 1.8k 1.4× 1.1k 1.5× 95 0.4× 525 3.0× 171 1.0× 130 2.8k
Nishant Jain 1.4k 1.1× 880 1.3× 52 0.2× 186 1.1× 177 1.1× 86 2.2k
Régis Millet 501 0.4× 663 1.0× 116 0.5× 373 2.1× 117 0.7× 71 1.4k
Amaury Farce 775 0.6× 935 1.4× 25 0.1× 186 1.1× 263 1.6× 71 1.9k
Andreas Link 813 0.6× 1.4k 2.0× 86 0.4× 229 1.3× 205 1.2× 121 2.3k
Raphaël Frédérick 703 0.5× 1.2k 1.8× 48 0.2× 188 1.1× 226 1.4× 80 2.5k
Paul C. Trippier 827 0.6× 802 1.2× 31 0.1× 224 1.3× 149 0.9× 55 1.8k
Joachim Mittendorf 435 0.3× 584 0.9× 48 0.2× 112 0.6× 58 0.3× 29 1.4k
Maria Paola Giovannoni 812 0.6× 939 1.4× 25 0.1× 267 1.5× 150 0.9× 106 1.8k

Countries citing papers authored by M Cara

Since Specialization
Citations

This map shows the geographic impact of M Cara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Cara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Cara more than expected).

Fields of papers citing papers by M Cara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Cara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Cara. The network helps show where M Cara may publish in the future.

Co-authorship network of co-authors of M Cara

This figure shows the co-authorship network connecting the top 25 collaborators of M Cara. A scholar is included among the top collaborators of M Cara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Cara. M Cara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mariotto, Elena, Francisco José Aguilar Troyano, Emilio Parisini, et al.. (2022). Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors. Pharmaceutics. 14(4). 715–715. 5 indexed citations
2.
Mariotto, Elena, Pablo Ríos‐Marco, Ramón Hurtado‐Guerrero, et al.. (2021). Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors. Pharmaceutics. 13(9). 1360–1360. 4 indexed citations
3.
Jabalera, Ylenia, Alberto Sola‐Leyva, Guillermo R. Iglesias, et al.. (2019). Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy. Pharmaceutics. 11(8). 408–408. 26 indexed citations
4.
Romagnoli, Romeo, Filippo Prencipe, Paola Oliva, et al.. (2019). Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors. Journal of Medicinal Chemistry. 62(3). 1274–1290. 39 indexed citations
5.
Mariotto, Elena, Giampietro Viola, Roberto Ronca, et al.. (2018). Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer. Cancers. 10(10). 391–391. 29 indexed citations
6.
Mariotto, Elena, Roberta Bortolozzi, Davide Carta, et al.. (2018). EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells. Biochemical Pharmacology. 155. 213–223. 25 indexed citations
7.
Romagnoli, Romeo, Pier Giovanni Baraldi, Filippo Prencipe, et al.. (2017). Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents. European Journal of Medicinal Chemistry. 134. 258–270. 28 indexed citations
8.
Romagnoli, Romeo, Pier Giovanni Baraldi, Filippo Prencipe, et al.. (2016). Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole. Scientific Reports. 6(1). 26602–26602. 32 indexed citations
9.
Cara, M, et al.. (2012). In silico pharmacology for a multidisciplinary drug discovery process. Drug metabolism and drug interactions. 27(4). 199–207. 28 indexed citations
10.
López, Pedro Juan Tárraga, et al.. (2011). Hipotiroidismo subclínico y factores de riesgo cardiovascular. Nutrición Hospitalaria. 26(6). 1355–1362. 7 indexed citations
11.
12.
Cara, M, Ana Conejo‐García, Juan Antonio Marchal, et al.. (2010). New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. European Journal of Medicinal Chemistry. 46(1). 249–258. 40 indexed citations
13.
Romagnoli, Romeo, Pier Giovanni Baraldi, Olga Cruz‐López, et al.. (2010). Symmetrical α-bromoacryloylamido diaryldienone derivatives as a novel series of antiproliferative agents. Design, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 20(9). 2733–2739. 2 indexed citations
14.
MacMillan, Karen S., M Cara, Romeo Romagnoli, et al.. (2009). Synthesis and evaluation of a thio analogue of duocarmycin SA. Bioorganic & Medicinal Chemistry Letters. 19(24). 6962–6965. 10 indexed citations
15.
Romagnoli, Romeo, Pier Giovanni Baraldi, Olga Cruz‐López, M Cara, & Delia Preti. (2008). α-Halogenoacrylic Derivatives of Antitumor Agents. Mini-Reviews in Medicinal Chemistry. 9(1). 81–94. 12 indexed citations
16.
Carriòn, María Dora, M Cara, M. Encarnación Camacho, et al.. (2008). Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III). European Journal of Medicinal Chemistry. 43(11). 2579–2591. 40 indexed citations
17.
Romagnoli, Romeo, Pier Giovanni Baraldi, Olga Cruz‐López, et al.. (2008). The P2X7receptor as a therapeutic target. Expert Opinion on Therapeutic Targets. 12(5). 647–661. 77 indexed citations
18.
López, Pedro Juan Tárraga, et al.. (2006). Tratamiento de la insuficiencia venosa crónica y calidad de vida en una Zona Básica de Salud. 452–463. 1 indexed citations
19.
Cara, M, et al.. (2006). Constipation in the population over 50 years of age in Albacete province. Revista Española de Enfermedades Digestivas. 98(6). 449–59. 11 indexed citations
20.
Anglani, Franca, Patrizia Bernich, M Cara, et al.. (2006). Family history may be misleading in the diagnosis of Dent’s disease. Urological Research. 34(1). 61–63. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alaa M. Hayallah Breakdown of academic impact, for papers by Olga Bruno Breakdown of academic impact, for papers by Nishant Jain Breakdown of academic impact, for papers by Régis Millet Breakdown of academic impact, for papers by Amaury Farce Breakdown of academic impact, for papers by Andreas Link Breakdown of academic impact, for papers by Raphaël Frédérick Breakdown of academic impact, for papers by Paul C. Trippier Breakdown of academic impact, for papers by Joachim Mittendorf Breakdown of academic impact, for papers by Maria Paola Giovannoni
Rankless by CCL
2026